{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:15:14Z","timestamp":1788999314500,"version":"build-2803163510"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T00:00:00Z","timestamp":1617494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T00:00:00Z","timestamp":1617494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA217798"],"award-info":[{"award-number":["P01 CA217798"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA210637"],"award-info":[{"award-number":["R01 CA210637"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA183459"],"award-info":[{"award-number":["R01 CA183459"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA195586"],"award-info":[{"award-number":["R01 CA195586"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA228524"],"award-info":[{"award-number":["R01 CA228524"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA200466"],"award-info":[{"award-number":["U01 CA200466"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA210240"],"award-info":[{"award-number":["U01 CA210240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["F99 CA234962"],"award-info":[{"award-number":["F99 CA234962"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010537","name":"Nebraska Department of Health and Human Services","doi-asserted-by":"publisher","award":["LB595"],"award-info":[{"award-number":["LB595"]}],"id":[{"id":"10.13039\/100010537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s10555-021-09959-1","type":"journal-article","created":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T12:02:20Z","timestamp":1617537740000},"page":"575-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mucins reprogram stemness, metabolism and promote chemoresistance during cancer progression"],"prefix":"10.1007","volume":"40","author":[{"given":"Saravanakumar","family":"Marimuthu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchita","family":"Rauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koelina","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imayavaramban","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surinder K.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5744-193X","authenticated-orcid":false,"given":"Moorthy P.","family":"Ponnusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,4]]},"reference":[{"issue":"3","key":"9959_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000453594","volume":"9","author":"JPM van Putten","year":"2017","unstructured":"van Putten, J. P. M., & Strijbis, K. (2017). Transmembrane mucins: Signaling receptors at the intersection of inflammation and cancer. Journal of Innate Immunity, 9(3), 281\u2013299. https:\/\/doi.org\/10.1159\/000453594.","journal-title":"Journal of Innate Immunity"},{"issue":"3","key":"9959_CR2","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000198115","volume":"17","author":"JF Forstner","year":"1978","unstructured":"Forstner, J. F. (1978). Intestinal mucins in health and disease. Digestion, 17(3), 234\u2013263. https:\/\/doi.org\/10.1159\/000198115.","journal-title":"Digestion"},{"issue":"10","key":"9959_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nrgastro.2013.120","volume":"10","author":"S Kaur","year":"2013","unstructured":"Kaur, S., Kumar, S., Momi, N., Sasson, A. R., & Batra, S. K. (2013). Mucins in pancreatic cancer and its microenvironment. Nature Reviews. Gastroenterology & Hepatology, 10(10), 607\u2013620. https:\/\/doi.org\/10.1038\/nrgastro.2013.120.","journal-title":"Nature Reviews. Gastroenterology & Hepatology"},{"issue":"4","key":"9959_CR4","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1096\/fj.07-9673rev","volume":"22","author":"P Chaturvedi","year":"2008","unstructured":"Chaturvedi, P., Singh, A. P., & Batra, S. K. (2008). Structure, evolution, and biology of the MUC4 mucin. The FASEB Journal, 22(4), 966\u2013981. https:\/\/doi.org\/10.1096\/fj.07-9673rev.","journal-title":"The FASEB Journal"},{"key":"9959_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.critrevonc.2017.12.006","volume":"122","author":"SS Dhanisha","year":"2018","unstructured":"Dhanisha, S. S., Guruvayoorappan, C., Drishya, S., & Abeesh, P. (2018). Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets. Critical Reviews in Oncology\/Hematology, 122, 98\u2013122. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.12.006.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"5","key":"9959_CR6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/carcin\/bgy019","volume":"39","author":"SR Krishn","year":"2018","unstructured":"Krishn, S. R., Ganguly, K., Kaur, S., & Batra, S. K. (2018). Ramifications of secreted mucin MUC5AC in malignant journey: A holistic view. Carcinogenesis, 39(5), 633\u2013651. https:\/\/doi.org\/10.1093\/carcin\/bgy019.","journal-title":"Carcinogenesis"},{"issue":"3","key":"9959_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10555-020-09896-5","volume":"39","author":"K Ganguly","year":"2020","unstructured":"Ganguly, K., Rauth, S., Marimuthu, S., Kumar, S., & Batra, S. K. (2020). Unraveling mucin domains in cancer and metastasis: When protectors become predators. Cancer Metastasis Reviews, 39(3), 647\u2013659. https:\/\/doi.org\/10.1007\/s10555-020-09896-5.","journal-title":"Cancer Metastasis Reviews"},{"issue":"1","key":"9959_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/jto.0000000000000404","volume":"10","author":"I Lakshmanan","year":"2015","unstructured":"Lakshmanan, I., Ponnusamy, M. P., Macha, M. A., Haridas, D., Majhi, P. D., Kaur, S., Jain, M., Batra, S. K., & Ganti, A. K. (2015). Mucins in lung cancer: Diagnostic, prognostic, and therapeutic implications. Journal of Thoracic Oncology, 10(1), 19\u201327. https:\/\/doi.org\/10.1097\/jto.0000000000000404.","journal-title":"Journal of Thoracic Oncology"},{"key":"9959_CR9","doi-asserted-by":"publisher","unstructured":"Pothuraju, R., Krishn, S. R., Gautam, S. K., Pai, P., Ganguly, K., Chaudhary, S., Rachagani, S., Kaur, S., & Batra, S. K. (2020). Mechanistic and functional shades of mucins and associated glycans in colon cancer. Cancers (Basel), 12(3). https:\/\/doi.org\/10.3390\/cancers12030649.","DOI":"10.3390\/cancers12030649"},{"key":"9959_CR10","doi-asserted-by":"publisher","first-page":"101391","DOI":"10.1016\/j.smim.2020.101391","volume":"47","author":"SK Gautam","year":"2020","unstructured":"Gautam, S. K., Kumar, S., Dam, V., Ghersi, D., Jain, M., & Batra, S. K. (2020). MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy. Seminars in Immunology, 47, 101391. https:\/\/doi.org\/10.1016\/j.smim.2020.101391.","journal-title":"Seminars in Immunology"},{"issue":"20","key":"9959_CR11","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1038\/onc.2010.87","volume":"29","author":"S Bafna","year":"2010","unstructured":"Bafna, S., Kaur, S., & Batra, S. K. (2010). Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene, 29(20), 2893\u20132904. https:\/\/doi.org\/10.1038\/onc.2010.87.","journal-title":"Oncogene"},{"issue":"6","key":"9959_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/1078-0432.Ccr-16-0862","volume":"23","author":"CV Rao","year":"2017","unstructured":"Rao, C. V., Janakiram, N. B., & Mohammed, A. (2017). Molecular pathways: Mucins and drug delivery in cancer. Clinical Cancer Research, 23(6), 1373\u20131378. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-0862.","journal-title":"Clinical Cancer Research"},{"key":"9959_CR13","doi-asserted-by":"publisher","first-page":"D1192","DOI":"10.2741\/moniaux","volume":"6","author":"N Moniaux","year":"2001","unstructured":"Moniaux, N., Escande, F., Porchet, N., Aubert, J. P., & Batra, S. K. (2001). Structural organization and classification of the human mucin genes. Frontiers in Bioscience, 6, D1192\u2013D1206. https:\/\/doi.org\/10.2741\/moniaux.","journal-title":"Frontiers in Bioscience"},{"issue":"5","key":"9959_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/SLA.0b013e3182352647","volume":"254","author":"M Messager","year":"2011","unstructured":"Messager, M., Lefevre, J. H., Pichot-Delahaye, V., Souadka, A., Piessen, G., & Mariette, C. (2011). The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: A multicenter comparative study. Annals of Surgery, 254(5), 684\u2013693; discussion 693. https:\/\/doi.org\/10.1097\/SLA.0b013e3182352647.","journal-title":"Annals of Surgery"},{"issue":"1","key":"9959_CR15","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","volume":"532","author":"J Leal","year":"2017","unstructured":"Leal, J., Smyth, H. D. C., & Ghosh, D. (2017). Physicochemical properties of mucus and their impact on transmucosal drug delivery. International Journal of Pharmaceutics, 532(1), 555\u2013572. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.09.018.","journal-title":"International Journal of Pharmaceutics"},{"issue":"6","key":"9959_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/js950381s","volume":"85","author":"PG Bhat","year":"1996","unstructured":"Bhat, P. G., Flanagan, D. R., & Donovan, M. D. (1996). Drug diffusion through cystic fibrotic mucus: Steady-state permeation, rheologic properties, and glycoprotein morphology. Journal of Pharmaceutical Sciences, 85(6), 624\u2013630. https:\/\/doi.org\/10.1021\/js950381s.","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"9959_CR17","first-page":"1372","volume":"7","author":"H Suh","year":"2017","unstructured":"Suh, H., Pillai, K., & Morris, D. L. (2017). Mucins in pancreatic cancer: Biological role, implications in carcinogenesis and applications in diagnosis and therapy. American Journal of Cancer Research, 7(6), 1372\u20131383.","journal-title":"American Journal of Cancer Research"},{"issue":"1","key":"9959_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.ejca.2008.10.008","volume":"45","author":"AV Kalra","year":"2009","unstructured":"Kalra, A. V., & Campbell, R. B. (2009). Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. European Journal of Cancer, 45(1), 164\u2013173. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.008.","journal-title":"European Journal of Cancer"},{"issue":"1-2","key":"9959_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijpharm.2004.11.028","volume":"290","author":"LR Shaw","year":"2005","unstructured":"Shaw, L. R., Irwin, W. J., Grattan, T. J., & Conway, B. R. (2005). The influence of excipients on the diffusion of ibuprofen and paracetamol in gastric mucus. International Journal of Pharmaceutics, 290(1-2), 145\u2013154. https:\/\/doi.org\/10.1016\/j.ijpharm.2004.11.028.","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"9959_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","volume":"453","author":"HH Sigurdsson","year":"2013","unstructured":"Sigurdsson, H. H., Kirch, J., & Lehr, C. M. (2013). Mucus as a barrier to lipophilic drugs. International Journal of Pharmaceutics, 453(1), 56\u201364. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.05.040.","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"9959_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbcan.2014.04.008","volume":"1846","author":"N Jonckheere","year":"2014","unstructured":"Jonckheere, N., Skrypek, N., & Van Seuningen, I. (2014). Mucins and tumor resistance to chemotherapeutic drugs. Biochimica et Biophysica Acta, 1846(1), 142\u2013151. https:\/\/doi.org\/10.1016\/j.bbcan.2014.04.008.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"8","key":"9959_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0968-0004(90)90014-3","volume":"15","author":"N Jentoft","year":"1990","unstructured":"Jentoft, N. (1990). Why are proteins O-glycosylated? Trends in Biochemical Sciences, 15(8), 291\u2013294. https:\/\/doi.org\/10.1016\/0968-0004(90)90014-3.","journal-title":"Trends in Biochemical Sciences"},{"key":"9959_CR23","doi-asserted-by":"crossref","unstructured":"van de Wiel-van Kemenade, E., Ligtenberg, M. J., de Boer, A. J., Buijs, F., Vos, H. L., Melief, C.\u00a0J., Hilkens, J., & Figdor, C. G. (1993). Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell\u00a0interaction. Journal of Immunology, 151(2), 767\u2013776.","DOI":"10.4049\/jimmunol.151.2.767"},{"issue":"1-2","key":"9959_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10555-018-09775-0","volume":"38","author":"R Bhatia","year":"2019","unstructured":"Bhatia, R., Gautam, S. K., Cannon, A., Thompson, C., Hall, B. R., Aithal, A., Banerjee, K., Jain, M., Solheim, J. C., Kumar, S., & Batra, S. K. (2019). Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metastasis Reviews, 38(1-2), 223\u2013236. https:\/\/doi.org\/10.1007\/s10555-018-09775-0.","journal-title":"Cancer Metastasis Reviews"},{"issue":"1","key":"9959_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrc1251","volume":"4","author":"MA Hollingsworth","year":"2004","unstructured":"Hollingsworth, M. A., & Swanson, B. J. (2004). Mucins in cancer: Protection and control of the cell surface. Nature Reviews. Cancer, 4(1), 45\u201360. https:\/\/doi.org\/10.1038\/nrc1251.","journal-title":"Nature Reviews. Cancer"},{"issue":"6","key":"9959_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","volume":"20","author":"S Nath","year":"2014","unstructured":"Nath, S., & Mukherjee, P. (2014). MUC1: A multifaceted oncoprotein with a key role in cancer progression. Trends in Molecular Medicine, 20(6), 332\u2013342. https:\/\/doi.org\/10.1016\/j.molmed.2014.02.007.","journal-title":"Trends in Molecular Medicine"},{"issue":"6","key":"9959_CR27","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1038\/oncsis.2013.16","volume":"2","author":"S Nath","year":"2013","unstructured":"Nath, S., Daneshvar, K., Roy, L. D., Grover, P., Kidiyoor, A., Mosley, L., Sahraei, M., & Mukherjee, P. (2013). MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. Oncogenesis, 2(6), e51. https:\/\/doi.org\/10.1038\/oncsis.2013.16.","journal-title":"Oncogenesis"},{"issue":"14","key":"9959_CR28","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.1073\/pnas.0812029106","volume":"106","author":"SP Pitroda","year":"2009","unstructured":"Pitroda, S. P., Khodarev, N. N., Beckett, M. A., Kufe, D. W., & Weichselbaum, R. R. (2009). MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment. Proceedings of the National Academy of Sciences of the United States of America, 106(14), 5837\u20135841. https:\/\/doi.org\/10.1073\/pnas.0812029106.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"9959_CR29","doi-asserted-by":"publisher","first-page":"e2980","DOI":"10.1038\/cddis.2017.378","volume":"8","author":"W Jin","year":"2017","unstructured":"Jin, W., Liao, X., Lv, Y., Pang, Z., Wang, Y., Li, Q., Liao, Y., Ye, Q., Chen, G., Zhao, K., & Huang, L. (2017). MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner. Cell Death & Disease, 8(8), e2980. https:\/\/doi.org\/10.1038\/cddis.2017.378.","journal-title":"Cell Death & Disease"},{"issue":"1","key":"9959_CR30","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1038\/oncsis.2015.47","volume":"5","author":"SY Ham","year":"2016","unstructured":"Ham, S. Y., Kwon, T., Bak, Y., Yu, J. H., Hong, J., Lee, S. K., Yu, D. Y., & Yoon, D. Y. (2016). Mucin 1-mediated chemoresistance in lung cancer cells. Oncogenesis, 5(1), e185. https:\/\/doi.org\/10.1038\/oncsis.2015.47.","journal-title":"Oncogenesis"},{"issue":"9","key":"9959_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1593\/neo.10576","volume":"12","author":"W Hagmann","year":"2010","unstructured":"Hagmann, W., Jesnowski, R., & L\u00f6hr, J. M. (2010). Interdependence of gemcitabine treatment, transporter expression, and resistance in human pancreatic carcinoma cells. Neoplasia, 12(9), 740\u2013747. https:\/\/doi.org\/10.1593\/neo.10576.","journal-title":"Neoplasia"},{"issue":"1","key":"9959_CR32","first-page":"119","volume":"5","author":"W Wang","year":"1999","unstructured":"Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999). The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clinical Cancer Research, 5(1), 119\u2013127.","journal-title":"Clinical Cancer Research"},{"issue":"21","key":"9959_CR33","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1038\/sj.onc.1206390","volume":"22","author":"A Arlt","year":"2003","unstructured":"Arlt, A., Gehrz, A., M\u00fcerk\u00f6ster, S., Vorndamm, J., Kruse, M. L., F\u00f6lsch, U. R., & Sch\u00e4fer, H. (2003). Role of NF-kappaB and Akt\/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene, 22(21), 3243\u20133251. https:\/\/doi.org\/10.1038\/sj.onc.1206390.","journal-title":"Oncogene"},{"issue":"13","key":"9959_CR34","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/onc.2012.179","volume":"32","author":"N Skrypek","year":"2013","unstructured":"Skrypek, N., Duch\u00eane, B., Hebbar, M., Leteurtre, E., van Seuningen, I., & Jonckheere, N. (2013). The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family. Oncogene, 32(13), 1714\u20131723. https:\/\/doi.org\/10.1038\/onc.2012.179.","journal-title":"Oncogene"},{"issue":"2","key":"9959_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1158\/0008-5472.can-03-2636","volume":"64","author":"AP Singh","year":"2004","unstructured":"Singh, A. P., Moniaux, N., Chauhan, S. C., Meza, J. L., & Batra, S. K. (2004). Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Research, 64(2), 622\u2013630. https:\/\/doi.org\/10.1158\/0008-5472.can-03-2636.","journal-title":"Cancer Research"},{"key":"9959_CR36","doi-asserted-by":"publisher","unstructured":"Carraway, K. L., Perez, A., Idris, N., Jepson, S., Arango, M., Komatsu, M., Haq, B., Price-Schiavi\u00a0A., Zhang, J., & Carraway, C. (2002). Muc4\/sialomucin complex, the intramembrane ErbB2 ligand, in\u00a0cancer and epithelia: To protect and to survive. Progress in Nucleic Acid Research and Molecular\u00a0Biology, 71, 149\u2013185. https:\/\/doi.org\/10.1016\/s0079-6603(02)71043-x.","DOI":"10.1016\/s0079-6603(02)71043-x"},{"issue":"7","key":"9959_CR37","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1158\/0008-5472.Can-07-6041","volume":"68","author":"P Chaturvedi","year":"2008","unstructured":"Chaturvedi, P., Singh, A. P., Chakraborty, S., Chauhan, S. C., Bafna, S., Meza, J. L., Singh, P. K., Hollingsworth, M. A., Mehta, P. P., & Batra, S. K. (2008). MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Research, 68(7), 2065\u20132070. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-6041.","journal-title":"Cancer Research"},{"issue":"7","key":"9959_CR38","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1091\/mbc.e05-09-0895","volume":"17","author":"VP Ramsauer","year":"2006","unstructured":"Ramsauer, V. P., Pino, V., Farooq, A., Carothers Carraway, C. A., Salas, P. J., & Carraway, K. L. (2006). Muc4-ErbB2 complex formation and signaling in polarized CACO-2 epithelial cells indicate that Muc4 acts as an unorthodox ligand for ErbB2. Molecular Biology of the Cell, 17(7), 2931\u20132941. https:\/\/doi.org\/10.1091\/mbc.e05-09-0895.","journal-title":"Molecular Biology of the Cell"},{"issue":"4","key":"9959_CR39","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3892\/ijo.2014.2579","volume":"45","author":"SH Park","year":"2014","unstructured":"Park, S. H., Lee, J. H., Berek, J. S., & Hu, M. C. (2014). Auranofin displays anticancer activity against ovarian cancer cells through FOXO3 activation independent of p53. International Journal of Oncology, 45(4), 1691\u20131698. https:\/\/doi.org\/10.3892\/ijo.2014.2579.","journal-title":"International Journal of Oncology"},{"issue":"4","key":"9959_CR40","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.3892\/or.2017.5853","volume":"38","author":"JS Bae","year":"2017","unstructured":"Bae, J. S., Lee, J., Park, Y., Park, K., Kim, J. R., Cho, D. H., Jang, K. Y., & Park, S. H. (2017). Attenuation of MUC4 potentiates the anticancer activity of auranofin via regulation of the Her2\/Akt\/FOXO3 pathway in ovarian cancer cells. Oncology Reports, 38(4), 2417\u20132425. https:\/\/doi.org\/10.3892\/or.2017.5853.","journal-title":"Oncology Reports"},{"issue":"1","key":"9959_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-020-01156-y","volume":"19","author":"R Pothuraju","year":"2020","unstructured":"Pothuraju, R., Rachagani, S., Krishn, S. R., Chaudhary, S., Nimmakayala, R. K., Siddiqui, J. A., Ganguly, K., Lakshmanan, I., Cox, J. L., Mallya, K., Kaur, S., & Batra, S. K. (2020). Molecular implications of MUC5AC-CD44 axis in colorectal cancer progression and chemoresistance. Molecular Cancer, 19(1), 37. https:\/\/doi.org\/10.1186\/s12943-020-01156-y.","journal-title":"Molecular Cancer"},{"issue":"10","key":"9959_CR42","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/ijc.30651","volume":"140","author":"Y Sheng","year":"2017","unstructured":"Sheng, Y., Ng, C. P., Lourie, R., Shah, E. T., He, Y., Wong, K. Y., Seim, I., Oancea, I., Morais, C., Jeffery, P. L., Hooper, J., Gobe, G. C., & McGuckin, M. A. (2017). MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance. International Journal of Cancer, 140(10), 2351\u20132363. https:\/\/doi.org\/10.1002\/ijc.30651.","journal-title":"International Journal of Cancer"},{"key":"9959_CR43","doi-asserted-by":"publisher","unstructured":"Xu, Z., Liu, Y., Yang, Y., Wang, J., Zhang, G., Liu, Z., Fu, H., Wang, Z., Liu, H., & Xu, J. (2017).\u00a0High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma. Oncotarget, 8(5), 7548\u20137558. https:\/\/doi.org\/10.18632\/oncotarget.13692.","DOI":"10.18632\/oncotarget.13692"},{"issue":"14","key":"9959_CR44","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/1078-0432.Ccr-16-2530","volume":"23","author":"I Lakshmanan","year":"2017","unstructured":"Lakshmanan, I., Salfity, S., Seshacharyulu, P., Rachagani, S., Thomas, A., Das, S., Majhi, P. D., Nimmakayala, R. K., Vengoji, R., Lele, S. M., Ponnusamy, M. P., Batra, S. K., & Ganti, A. K. (2017). MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clinical Cancer Research, 23(14), 3906\u20133917. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-2530.","journal-title":"Clinical Cancer Research"},{"key":"9959_CR45","doi-asserted-by":"publisher","unstructured":"Das, S., Rachagani, S., Torres-Gonzalez, M. P., Lakshmanan, I., Majhi, P. D., Smith, L. M.,\u00a0Wagner, K., & Batra, S. K. (2015). Carboxyl-terminal domain of MUC16 imparts tumorigenic and\u00a0metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells. Oncotarget,\u00a06(8), 5772\u20135787. https:\/\/doi.org\/10.18632\/oncotarget.3308.","DOI":"10.18632\/oncotarget.3308"},{"issue":"3","key":"9959_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ygyno.2009.08.007","volume":"115","author":"M Boivin","year":"2009","unstructured":"Boivin, M., Lane, D., Pich\u00e9, A., & Rancourt, C. (2009). CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecologic Oncology, 115(3), 407\u2013413. https:\/\/doi.org\/10.1016\/j.ygyno.2009.08.007.","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"9959_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0092-8674(00)81692-x","volume":"100","author":"IL Weissman","year":"2000","unstructured":"Weissman, I. L. (2000). Stem cells: units of development, units of regeneration, and units in evolution. Cell, 100(1), 157\u2013168. https:\/\/doi.org\/10.1016\/s0092-8674(00)81692-x.","journal-title":"Cell"},{"issue":"6","key":"9959_CR48","doi-asserted-by":"publisher","first-page":"6196","DOI":"10.3390\/molecules17066196","volume":"17","author":"W Zhao","year":"2012","unstructured":"Zhao, W., Ji, X., Zhang, F., Li, L., & Ma, L. (2012). Embryonic stem cell markers. Molecules, 17(6), 6196\u20136236. https:\/\/doi.org\/10.3390\/molecules17066196.","journal-title":"Molecules"},{"issue":"6","key":"9959_CR49","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.2353\/ajpath.2010.090702","volume":"176","author":"Q Yan","year":"2010","unstructured":"Yan, Q., Yao, D., Wei, L. L., Huang, Y., Myers, J., Zhang, L., Xin, W., Shim, J., Man, Y., Petryniak, B., Gerson, S., Lowe, J. B., & Zhou, L. (2010). O-fucose modulates Notch-controlled blood lineage commitment. The American Journal of Pathology, 176(6), 2921\u20132934. https:\/\/doi.org\/10.2353\/ajpath.2010.090702.","journal-title":"The American Journal of Pathology"},{"issue":"12","key":"9959_CR50","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1002\/dvdy.22475","volume":"239","author":"A Seth","year":"2010","unstructured":"Seth, A., Machingo, Q. J., Fritz, A., & Shur, B. D. (2010). Core fucosylation is required for midline patterning during zebrafish development. Developmental Dynamics, 239(12), 3380\u20133390. https:\/\/doi.org\/10.1002\/dvdy.22475.","journal-title":"Developmental Dynamics"},{"issue":"7381","key":"9959_CR51","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves, M., & Maley, C. C. (2012). Clonal evolution in cancer. Nature, 481(7381), 306\u2013313. https:\/\/doi.org\/10.1038\/nature10762.","journal-title":"Nature"},{"key":"9959_CR52","doi-asserted-by":"publisher","unstructured":"Gupta, P. B., Onder, T. T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R. A., & Lander, E. S.\u00a0(2009). Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell,\u00a0138(4), 645\u2013659. https:\/\/doi.org\/10.1016\/j.cell.2009.06.034.","DOI":"10.1016\/j.cell.2009.06.034"},{"issue":"43","key":"9959_CR53","doi-asserted-by":"publisher","first-page":"30892","DOI":"10.1074\/jbc.M113.477158","volume":"288","author":"M Alam","year":"2013","unstructured":"Alam, M., Ahmad, R., Rajabi, H., Kharbanda, A., & Kufe, D. (2013). MUC1-C oncoprotein activates ERK \u2192 C\/EBP\u03b2 signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells. The Journal of Biological Chemistry, 288(43), 30892\u201330903. https:\/\/doi.org\/10.1074\/jbc.M113.477158.","journal-title":"The Journal of Biological Chemistry"},{"issue":"7","key":"9959_CR54","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1158\/0008-5472.Can-07-2249","volume":"68","author":"K Engelmann","year":"2008","unstructured":"Engelmann, K., Shen, H., & Finn, O. J. (2008). MCF7 side population cells with characteristics of cancer stem\/progenitor cells express the tumor antigen MUC1. Cancer Research, 68(7), 2419\u20132426. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-2249.","journal-title":"Cancer Research"},{"issue":"17","key":"9959_CR55","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.1158\/0008-5472.Can-13-0677","volume":"73","author":"D Stroopinsky","year":"2013","unstructured":"Stroopinsky, D., Rosenblatt, J., Ito, K., Mills, H., Yin, L., Rajabi, H., Vasir, B., Kufe, T., Luptakova, K., Arnason, J., Nardella, C., Levine, J. D., Joyce, R. M., Galinsky, I., Reiter, Y., Stone, R. M., Pandolfi, P. P., Kufe, D., & Avigan, D. (2013). MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells. Cancer Research, 73(17), 5569\u20135579. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-0677.","journal-title":"Cancer Research"},{"key":"9959_CR56","doi-asserted-by":"publisher","first-page":"106850","DOI":"10.1016\/j.intimp.2020.106850","volume":"88","author":"M Guo","year":"2020","unstructured":"Guo, M., Luo, B., Pan, M., Li, M., Xu, H., Zhao, F., & Dou, J. (2020). Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer. International Immunopharmacology, 88, 106850. https:\/\/doi.org\/10.1016\/j.intimp.2020.106850.","journal-title":"International Immunopharmacology"},{"key":"9959_CR57","doi-asserted-by":"publisher","first-page":"110804","DOI":"10.1016\/j.biopha.2020.110804","volume":"132","author":"M Guo","year":"2020","unstructured":"Guo, M., You, C., Dong, W., Luo, B., Wu, Y., Chen, Y., Li, J., Pan, M., Li, M., Zhao, F., & Dou, J. (2020). The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy. Biomedicine & Pharmacotherapy, 132, 110804. https:\/\/doi.org\/10.1016\/j.biopha.2020.110804.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"7","key":"9959_CR58","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/jso.23316","volume":"107","author":"JM Curry","year":"2013","unstructured":"Curry, J. M., Thompson, K. J., Rao, S. G., Besmer, D. M., Murphy, A. M., Grdzelishvili, V. Z., Ahrens, W. A., McKillop, I. H., Sindram, D., Iannitti, D. A., Martinie, J. B., & Mukherjee, P. (2013). The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Journal of Surgical Oncology, 107(7), 713\u2013722. https:\/\/doi.org\/10.1002\/jso.23316.","journal-title":"Journal of Surgical Oncology"},{"issue":"1","key":"9959_CR59","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1757-2215-4-7","volume":"4","author":"MP Ponnusamy","year":"2011","unstructured":"Ponnusamy, M. P., Seshacharyulu, P., Vaz, A., Dey, P., & Batra, S. K. (2011). MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. Journal of Ovarian Research, 4(1), 7. https:\/\/doi.org\/10.1186\/1757-2215-4-7.","journal-title":"Journal of Ovarian Research"},{"issue":"1","key":"9959_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2010.02.015","volume":"295","author":"M Mimeault","year":"2010","unstructured":"Mimeault, M., Johansson, S. L., Senapati, S., Momi, N., Chakraborty, S., & Batra, S. K. (2010). MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem\/progenitor cells and their progenies. Cancer Letters, 295(1), 69\u201384. https:\/\/doi.org\/10.1016\/j.canlet.2010.02.015.","journal-title":"Cancer Letters"},{"issue":"2","key":"9959_CR61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1158\/1535-7163.Mct-08-0924","volume":"8","author":"A Jimeno","year":"2009","unstructured":"Jimeno, A., Feldmann, G., Su\u00e1rez-Gauthier, A., Rasheed, Z., Solomon, A., Zou, G. M., Rubio-Viqueira, B., Garc\u00eda-Garc\u00eda, E., L\u00f3pez-R\u00edos, F., Matsui, W., Maitra, A., & Hidalgo, M. (2009). A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Molecular Cancer Therapeutics, 8(2), 310\u2013314. https:\/\/doi.org\/10.1158\/1535-7163.Mct-08-0924.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"6","key":"9959_CR62","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3748\/wjg.14.925","volume":"14","author":"J Zhou","year":"2008","unstructured":"Zhou, J., Wang, C. Y., Liu, T., Wu, B., Zhou, F., Xiong, J. X., Wu, H. S., Tao, J., Zhao, G., Yang, M., & Gou, S. M. (2008). Persistence of side population cells with high drug efflux capacity in pancreatic cancer. World Journal of Gastroenterology, 14(6), 925\u2013930. https:\/\/doi.org\/10.3748\/wjg.14.925.","journal-title":"World Journal of Gastroenterology"},{"key":"9959_CR63","doi-asserted-by":"publisher","unstructured":"Ganguly, K., Krishn, S. R., Rachagani, S., Jahan, R., Shah, A., Nallasamy, P., Rauth, S., Atri, P., Cox, J. L., Pothuraju, R., Smith, L. M., Ayala, S., Evans, C., Ponusamy, M. P., Kumar, S., Kaur, S., & Batra, S. K. (2020). Secretory mucin 5 AC promotes neoplastic progression by augmenting KLF4-mediated pancreatic cancer cell stemness. Cancer Research. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-1293.","DOI":"10.1158\/0008-5472.Can-20-1293"},{"key":"9959_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13048-015-0132-8","volume":"8","author":"H Zhang","year":"2015","unstructured":"Zhang, H., Yang, Y., Wang, Y., Gao, X., Wang, W., Liu, H., He, H., Liang, Y., Pan, K., Wu, H., Shi, J., Xue, H., Liang, L., Cai, Z., Fan, Y., & Zhang, Y. (2015). Relationship of tumor marker CA125 and ovarian tumor stem cells: Preliminary identification. Journal of Ovarian Research, 8, 19. https:\/\/doi.org\/10.1186\/s13048-015-0132-8.","journal-title":"Journal of Ovarian Research"},{"issue":"6","key":"9959_CR65","doi-asserted-by":"publisher","first-page":"e66558","DOI":"10.1371\/journal.pone.0066558","volume":"8","author":"S Lim","year":"2013","unstructured":"Lim, S., Becker, A., Zimmer, A., Lu, J., Buettner, R., & Kirfel, J. (2013). SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance. PLoS One, 8(6), e66558. https:\/\/doi.org\/10.1371\/journal.pone.0066558.","journal-title":"PLoS One"},{"issue":"5","key":"9959_CR66","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.surg.2013.05.004","volume":"154","author":"S Yamada","year":"2013","unstructured":"Yamada, S., Fuchs, B. C., Fujii, T., Shimoyama, Y., Sugimoto, H., Nomoto, S., Takeda, S., Tanabe, K. K., Kodera, Y., & Nakao, A. (2013). Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer. Surgery, 154(5), 946\u2013954. https:\/\/doi.org\/10.1016\/j.surg.2013.05.004.","journal-title":"Surgery"},{"issue":"6","key":"9959_CR67","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/bjc.2011.34","volume":"104","author":"M Comamala","year":"2011","unstructured":"Comamala, M., Pinard, M., Th\u00e9riault, C., Matte, I., Albert, A., Boivin, M., Beaudin, J., Pich\u00e9, A., & Rancourt, C. (2011). Downregulation of cell surface CA125\/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells. British Journal of Cancer, 104(6), 989\u2013999. https:\/\/doi.org\/10.1038\/bjc.2011.34.","journal-title":"British Journal of Cancer"},{"issue":"8","key":"9959_CR68","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.yexcr.2009.02.011","volume":"315","author":"G Horn","year":"2009","unstructured":"Horn, G., Gaziel, A., Wreschner, D. H., Smorodinsky, N. I., & Ehrlich, M. (2009). ERK and PI3K regulate different aspects of the epithelial to mesenchymal transition of mammary tumor cells induced by truncated MUC1. Experimental Cell Research, 315(8), 1490\u20131504. https:\/\/doi.org\/10.1016\/j.yexcr.2009.02.011.","journal-title":"Experimental Cell Research"},{"issue":"12","key":"9959_CR69","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/onc.2010.526","volume":"30","author":"LD Roy","year":"2011","unstructured":"Roy, L. D., Sahraei, M., Subramani, D. B., Besmer, D., Nath, S., Tinder, T. L., Bajaj, E., Shanmugam, K., Lee, Y. Y., Hwang, S. I. L., Gendler, S. J., & Mukherjee, P. (2011). MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. Oncogene, 30(12), 1449\u20131459. https:\/\/doi.org\/10.1038\/onc.2010.526.","journal-title":"Oncogene"},{"issue":"42","key":"9959_CR70","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1038\/onc.2010.309","volume":"29","author":"MP Ponnusamy","year":"2010","unstructured":"Ponnusamy, M. P., Lakshmanan, I., Jain, M., Das, S., Chakraborty, S., Dey, P., & Batra, S. K. (2010). MUC4 mucin-induced epithelial to mesenchymal transition: A novel mechanism for metastasis of human ovarian cancer cells. Oncogene, 29(42), 5741\u20135754. https:\/\/doi.org\/10.1038\/onc.2010.309.","journal-title":"Oncogene"},{"issue":"31","key":"9959_CR71","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1038\/onc.2015.478","volume":"35","author":"I Lakshmanan","year":"2016","unstructured":"Lakshmanan, I., Rachagani, S., Hauke, R., Krishn, S. R., Paknikar, S., Seshacharyulu, P., Karmakar, S., Nimmakayala, R. K., Kaushik, G., Johansson, S. L., Carey, G. B., Ponnusamy, M. P., Kaur, S., Batra, S. K., & Ganti, A. K. (2016). MUC5AC interactions with integrin \u03b24 enhances the migration of lung cancer cells through FAK signaling. Oncogene, 35(31), 4112\u20134121. https:\/\/doi.org\/10.1038\/onc.2015.478.","journal-title":"Oncogene"},{"issue":"10","key":"9959_CR72","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1158\/1535-7163.Mct-19-0156","volume":"18","author":"T Hata","year":"2019","unstructured":"Hata, T., Rajabi, H., Yamamoto, M., Jin, C., Ahmad, R., Zhang, Y., Kui, L., Li, W., Yasumizu, Y., Hong, D., Miyo, M., Hiraki, M., Maeda, T., Suzuki, Y., Takahashi, H., Samur, M., & Kufe, D. (2019). Targeting MUC1-C inhibits TWIST1 signaling in triple-negative breast cancer. Molecular Cancer Therapeutics, 18(10), 1744\u20131754. https:\/\/doi.org\/10.1158\/1535-7163.Mct-19-0156.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"13","key":"9959_CR73","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/onc.2013.114","volume":"33","author":"H Rajabi","year":"2014","unstructured":"Rajabi, H., Alam, M., Takahashi, H., Kharbanda, A., Guha, M., Ahmad, R., & Kufe, D. (2014). MUC1-C oncoprotein activates the ZEB1\/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene, 33(13), 1680\u20131689. https:\/\/doi.org\/10.1038\/onc.2013.114.","journal-title":"Oncogene"},{"issue":"6","key":"9959_CR74","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.18632\/oncotarget.23966","volume":"9","author":"P Grover","year":"2018","unstructured":"Grover, P., Nath, S., Nye, M. D., Zhou, R., Ahmad, M., & Mukherjee, P. (2018). SMAD4-independent activation of TGF-\u03b2 signaling by MUC1 in a human pancreatic cancer cell line. Oncotarget, 9(6), 6897\u20136910. https:\/\/doi.org\/10.18632\/oncotarget.23966.","journal-title":"Oncotarget"},{"issue":"10","key":"9959_CR75","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1093\/carcin\/bgs225","volume":"33","author":"S Rachagani","year":"2012","unstructured":"Rachagani, S., Macha, M. A., Ponnusamy, M. P., Haridas, D., Kaur, S., Jain, M., & Batra, S. K. (2012). MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Carcinogenesis, 33(10), 1953\u20131964. https:\/\/doi.org\/10.1093\/carcin\/bgs225.","journal-title":"Carcinogenesis"},{"key":"9959_CR76","doi-asserted-by":"publisher","unstructured":"Muniyan, S., Haridas, D., Chugh, S., Rachagani, S., Lakshmanan, I., Gupta, S., Seshacharyulu,\u00a0P., Smith, L. M., Ponnusamy, M. P., & Batra S. K. (2016). MUC16 contributes to the metastasis of\u00a0pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes &\u00a0Cancer, 7(3\u20134), 110\u2013124. https:\/\/doi.org\/10.18632\/genesandcancer.104.","DOI":"10.18632\/genesandcancer.104"},{"issue":"5","key":"9959_CR77","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"2","key":"9959_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41416-019-0667-3","volume":"122","author":"C Frezza","year":"2020","unstructured":"Frezza, C. (2020). Metabolism and cancer: The future is now. British Journal of Cancer, 122(2), 133\u2013135. https:\/\/doi.org\/10.1038\/s41416-019-0667-3.","journal-title":"British Journal of Cancer"},{"key":"9959_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-77736-8_12","volume":"1063","author":"JG Jung","year":"2018","unstructured":"Jung, J. G., & Le, A. (2018). Targeting metabolic cross talk between cancer cells and cancer-associated fibroblasts. Advances in Experimental Medicine and Biology, 1063, 167\u2013178. https:\/\/doi.org\/10.1007\/978-3-319-77736-8_12.","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"34","key":"9959_CR80","doi-asserted-by":"publisher","first-page":"13787","DOI":"10.1073\/pnas.1203339109","volume":"109","author":"NV Chaika","year":"2012","unstructured":"Chaika, N. V., Gebregiworgis, T., Lewallen, M. E., Purohit, V., Radhakrishnan, P., Liu, X., Zhang, B., Mehla, K., Brown, R. B., Caffrey, T., Yu, F., Johnson, K. R., Powers, R., Hollingsworth, M. A., & Singh, P. K. (2012). MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America, 109(34), 13787\u201313792. https:\/\/doi.org\/10.1073\/pnas.1203339109.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"9959_CR81","doi-asserted-by":"publisher","first-page":"e28234","DOI":"10.1371\/journal.pone.0028234","volume":"6","author":"M Kosugi","year":"2011","unstructured":"Kosugi, M., Ahmad, R., Alam, M., Uchida, Y., & Kufe, D. (2011). MUC1-C oncoprotein regulates glycolysis and pyruvate kinase M2 activity in cancer cells. PLoS One, 6(11), e28234. https:\/\/doi.org\/10.1371\/journal.pone.0028234.","journal-title":"PLoS One"},{"issue":"20","key":"9959_CR82","doi-asserted-by":"publisher","first-page":"20607","DOI":"10.1074\/jbc.M310538200","volume":"279","author":"D Raina","year":"2004","unstructured":"Raina, D., Kharbanda, S., & Kufe, D. (2004). The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase\/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. The Journal of Biological Chemistry, 279(20), 20607\u201320612. https:\/\/doi.org\/10.1074\/jbc.M310538200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"9959_CR83","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbcan.2014.01.001","volume":"1845","author":"K Mehla","year":"2014","unstructured":"Mehla, K., & Singh, P. K. (2014). MUC1: A novel metabolic master regulator. Biochimica et Biophysica Acta, 1845(2), 126\u2013135. https:\/\/doi.org\/10.1016\/j.bbcan.2014.01.001.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"11","key":"9959_CR84","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/j.1349-7006.2004.tb02195.x","volume":"95","author":"K Yoshida","year":"2004","unstructured":"Yoshida, K., & Miki, Y. (2004). Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Science, 95(11), 866\u2013871. https:\/\/doi.org\/10.1111\/j.1349-7006.2004.tb02195.x.","journal-title":"Cancer Science"},{"issue":"19","key":"9959_CR85","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1158\/1078-0432.Ccr-17-1151","volume":"23","author":"V Gunda","year":"2017","unstructured":"Gunda, V., Souchek, J., Abrego, J., Shukla, S. K., Goode, G. D., Vernucci, E., Dasgupta, A., Chaika, N. V., King, R. J., Li, S., Wang, S., Yu, F., Bessho, T., Lin, C., & Singh, P. K. (2017). MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clinical Cancer Research, 23(19), 5881\u20135891. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-1151.","journal-title":"Clinical Cancer Research"},{"issue":"4","key":"9959_CR86","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1940-6207.Capr-16-0281","volume":"10","author":"T Chiyoda","year":"2017","unstructured":"Chiyoda, T., Hart, P. C., Eckert, M. A., McGregor, S. M., Lastra, R. R., Hamamoto, R., Nakamura, Y., Yamada, S. D., Olopade, O. I., Lengyel, E., & Romero, I. L. (2017). Loss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: A window of opportunity for ovarian cancer Chemoprevention. Cancer Prevention Research (Philadelphia, Pa.), 10(4), 255\u2013266. https:\/\/doi.org\/10.1158\/1940-6207.Capr-16-0281.","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"issue":"3","key":"9959_CR87","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/s1875-5364(20)30019-4","volume":"18","author":"X Fu","year":"2020","unstructured":"Fu, X., Tang, N., Xie, W. Q., Mao, L., & Qiu, Y. D. (2020). MUC1 promotes glycolysis through inhibiting BRCA1 expression in pancreatic cancer. Chinese Journal of Natural Medicines, 18(3), 178\u2013185. https:\/\/doi.org\/10.1016\/s1875-5364(20)30019-4.","journal-title":"Chinese Journal of Natural Medicines"},{"issue":"27","key":"9959_CR88","doi-asserted-by":"publisher","first-page":"19321","DOI":"10.1074\/jbc.M703222200","volume":"282","author":"Y Leng","year":"2007","unstructured":"Leng, Y., Cao, C., Ren, J., Huang, L., Chen, D., Ito, M., & Kufe, D. (2007). Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62. The Journal of Biological Chemistry, 282(27), 19321\u201319330. https:\/\/doi.org\/10.1074\/jbc.M703222200.","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"9959_CR89","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijo.2011.1308","volume":"40","author":"D Raina","year":"2012","unstructured":"Raina, D., Ahmad, R., Rajabi, H., Panchamoorthy, G., Kharbanda, S., & Kufe, D. (2012). Targeting cysteine-mediated dimerization of the MUC1-C oncoprotein in human cancer cells. International Journal of Oncology, 40(5), 1643\u20131649. https:\/\/doi.org\/10.3892\/ijo.2011.1308.","journal-title":"International Journal of Oncology"},{"issue":"5","key":"9959_CR90","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/1535-7163.Mct-10-1050","volume":"10","author":"D Raina","year":"2011","unstructured":"Raina, D., Kosugi, M., Ahmad, R., Panchamoorthy, G., Rajabi, H., Alam, M., Shimamura, T., Shapiro, G. I., Supko, J., Kharbanda, S., & Kufe, D. (2011). Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells. Molecular Cancer Therapeutics, 10(5), 806\u2013816. https:\/\/doi.org\/10.1158\/1535-7163.Mct-10-1050.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"7","key":"9959_CR91","doi-asserted-by":"publisher","first-page":"12019","DOI":"10.1002\/jcp.27863","volume":"234","author":"X GongSun","year":"2019","unstructured":"GongSun, X., Zhao, Y., Jiang, B., Xin, Z., Shi, M., Song, L., Qin, Q. M., Wang, Q., & Liu, X. Y. (2019). Inhibition of MUC1-C regulates metabolism by AKT pathway in esophageal squamous cell carcinoma. Journal of Cellular Physiology, 234(7), 12019\u201312028. https:\/\/doi.org\/10.1002\/jcp.27863.","journal-title":"Journal of Cellular Physiology"},{"issue":"2","key":"9959_CR92","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41389-018-0031-0","volume":"7","author":"S Kumari","year":"2018","unstructured":"Kumari, S., Khan, S., Gupta, S. C., Kashyap, V. K., Yallapu, M. M., Chauhan, S. C., & Jaggi, M. (2018). MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer. Oncogenesis, 7(2), 19. https:\/\/doi.org\/10.1038\/s41389-018-0031-0.","journal-title":"Oncogenesis"},{"issue":"10","key":"9959_CR93","doi-asserted-by":"publisher","first-page":"e26839","DOI":"10.1371\/journal.pone.0026839","volume":"6","author":"D Haridas","year":"2011","unstructured":"Haridas, D., Chakraborty, S., Ponnusamy, M. P., Lakshmanan, I., Rachagani, S., Cruz, E., Kumar, S., Das, S., Lele, S. M., Anderson, J. M., Wittel, U. A., Hollingsworth, M. A., & Batra, S. K. (2011). Pathobiological implications of MUC16 expression in pancreatic cancer. PLoS One, 6(10), e26839. https:\/\/doi.org\/10.1371\/journal.pone.0026839.","journal-title":"PLoS One"},{"key":"9959_CR94","doi-asserted-by":"publisher","unstructured":"Shukla, S. K., Gunda, V., Abrego, J., Haridas, D., Mishra, A., Souchek, J., Chaika, N. V., Yu, F.,\u00a0Sasson, A. R., Lazenby, A. J., Batra, S. K., & Singh, P. K. (2015). MUC16-mediated activation of mTOR\u00a0and c-Myc reprograms pancreatic cancer metabolism. Oncotarget, 6(22), 19118\u201319131. https:\/\/doi.org\/10.18632\/oncotarget.4078.","DOI":"10.18632\/oncotarget.4078"},{"issue":"3","key":"9959_CR95","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi, M., & Hall, M. N. (2014). Making new contacts: The mTOR network in metabolism and signalling crosstalk. Nature Reviews. Molecular Cell Biology, 15(3), 155\u2013162. https:\/\/doi.org\/10.1038\/nrm3757.","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"2","key":"9959_CR96","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2010.06.022","volume":"39","author":"K D\u00fcvel","year":"2010","unstructured":"D\u00fcvel, K., Yecies, J. L., Menon, S., Raman, P., Lipovsky, A. I., Souza, A. L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S., Vander Heiden, M. G., MacKeigan, J. P., Finan, P. M., Clish, C. B., Murphy, L. O., & Manning, B. D. (2010). Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Molecular Cell, 39(2), 171\u2013183. https:\/\/doi.org\/10.1016\/j.molcel.2010.06.022.","journal-title":"Molecular Cell"},{"issue":"10","key":"9959_CR97","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.bbalip.2013.08.001","volume":"1831","author":"DK Nomura","year":"2013","unstructured":"Nomura, D. K., & Cravatt, B. F. (2013). Lipid metabolism in cancer. Biochimica et Biophysica Acta, 1831(10), 1497\u20131498. https:\/\/doi.org\/10.1016\/j.bbalip.2013.08.001.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"9","key":"9959_CR98","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima, T., Seimiya, H., & Tsuruo, T. (2009). De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. British Journal of Cancer, 100(9), 1369\u20131372. https:\/\/doi.org\/10.1038\/sj.bjc.6605007.","journal-title":"British Journal of Cancer"},{"issue":"3","key":"9959_CR99","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.pcan.4500879","volume":"9","author":"Y Liu","year":"2006","unstructured":"Liu, Y. (2006). Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer. Prostate Cancer and Prostatic Diseases, 9(3), 230\u2013234. https:\/\/doi.org\/10.1038\/sj.pcan.4500879.","journal-title":"Prostate Cancer and Prostatic Diseases"},{"issue":"30","key":"9959_CR100","doi-asserted-by":"publisher","first-page":"24990","DOI":"10.1074\/jbc.M112.340083","volume":"287","author":"A Mukherjee","year":"2012","unstructured":"Mukherjee, A., Wu, J., Barbour, S., & Fang, X. (2012). Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells. The Journal of Biological Chemistry, 287(30), 24990\u201325000. https:\/\/doi.org\/10.1074\/jbc.M112.340083.","journal-title":"The Journal of Biological Chemistry"},{"key":"9959_CR101","doi-asserted-by":"publisher","unstructured":"Martel, P. M., Bingham, C. M., McGraw, C. J., Baker, C. L., Morganelli, P. M., Meng, M. L.,\u00a0Armstrong, J. M., Moncur, J. T., & Kinlaw, W. B., (2006). S14 protein in breast cancer cells: Direct\u00a0evidence of regulation by SREBP-1c, superinduction with progestin, and effects on cell\u00a0growth. Experimental Cell Research, 312(3), 278\u2013288. https:\/\/doi.org\/10.1016\/j.yexcr.2005.10.022.","DOI":"10.1016\/j.yexcr.2005.10.022"},{"issue":"20","key":"9959_CR102","doi-asserted-by":"publisher","first-page":"8547","DOI":"10.1158\/0008-5472.Can-08-1235","volume":"68","author":"T Migita","year":"2008","unstructured":"Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., Okumura, S., Nakagawa, K., & Ishikawa, Y. (2008). ATP citrate lyase: Activation and therapeutic implications in non-small cell lung cancer. Cancer Research, 68(20), 8547\u20138554. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-1235.","journal-title":"Cancer Research"},{"issue":"10","key":"9959_CR103","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez, J. A., & Lupu, R. (2007). Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature Reviews. Cancer, 7(10), 763\u2013777. https:\/\/doi.org\/10.1038\/nrc2222.","journal-title":"Nature Reviews. Cancer"},{"issue":"4","key":"9959_CR104","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/0008-5472.Can-07-2489","volume":"68","author":"E Furuta","year":"2008","unstructured":"Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y. Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., Kamada, S., Saito, K., Iiizumi, M., Liu, W., Ericsson, J., & Watabe, K. (2008). Fatty acid synthase gene is upregulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Research, 68(4), 1003\u20131011. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-2489.","journal-title":"Cancer Research"},{"issue":"3","key":"9959_CR105","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1042\/bst20170400","volume":"46","author":"J Taylor-Papadimitriou","year":"2018","unstructured":"Taylor-Papadimitriou, J., Burchell, J. M., Graham, R., & Beatson, R. (2018). Latest developments in MUC1 immunotherapy. Biochemical Society Transactions, 46(3), 659\u2013668. https:\/\/doi.org\/10.1042\/bst20170400.","journal-title":"Biochemical Society Transactions"},{"key":"9959_CR106","doi-asserted-by":"publisher","unstructured":"Panchamoorthy, G., Jin, C., Raina, D., Bharti, A., Yamamoto, M., Adeebge, D., Zhao, Q., Bronson, R., Jiang, S., Li, L., Suzuki, Y., Tagde, A., Ghoroghchian, P. P., Wong, K. K., Kharbanda, S., & Kufe, D. (2018). Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate. JCI Insight, 3(12). https:\/\/doi.org\/10.1172\/jci.insight.99880.","DOI":"10.1172\/jci.insight.99880"},{"issue":"1","key":"9959_CR107","doi-asserted-by":"publisher","first-page":"16678","DOI":"10.1038\/s41598-019-53099-0","volume":"9","author":"M Liberelle","year":"2019","unstructured":"Liberelle, M., Magnez, R., Thuru, X., Bencheikh, Y., Ravez, S., Quenon, C., Drucbert, A. S., Foulon, C., Melnyk, P., van Seuningen, I., & Leb\u00e8gue, N. (2019). MUC4-ErbB2 oncogenic complex: Binding studies using microscale thermophoresis. Scientific Reports, 9(1), 16678. https:\/\/doi.org\/10.1038\/s41598-019-53099-0.","journal-title":"Scientific Reports"},{"issue":"22","key":"9959_CR108","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1158\/0008-5472.Can-15-1050","volume":"75","author":"S Das","year":"2015","unstructured":"Das, S., & Batra, S. K. (2015). Understanding the unique attributes of MUC16 (CA125): Potential implications in targeted therapy. Cancer Research, 75(22), 4669\u20134674. https:\/\/doi.org\/10.1158\/0008-5472.Can-15-1050.","journal-title":"Cancer Research"},{"issue":"8","key":"9959_CR109","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14728222.2018.1498845","volume":"22","author":"A Aithal","year":"2018","unstructured":"Aithal, A., Rauth, S., Kshirsagar, P., Shah, A., Lakshmanan, I., Junker, W. M., Jain, M., Ponnusamy, M. P., & Batra, S. K. (2018). MUC16 as a novel target for cancer therapy. Expert Opinion on Therapeutic Targets, 22(8), 675\u2013686. https:\/\/doi.org\/10.1080\/14728222.2018.1498845.","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"6","key":"9959_CR110","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00262-013-1420-z","volume":"62","author":"SP Patel","year":"2013","unstructured":"Patel, S. P., Bristol, A., Saric, O., Wang, X. P., Dubeykovskiy, A., Arlen, P. M., & Morse, M. A. (2013). Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models. Cancer Immunology, Immunotherapy, 62(6), 1011\u20131019. https:\/\/doi.org\/10.1007\/s00262-013-1420-z.","journal-title":"Cancer Immunology, Immunotherapy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-021-09959-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-021-09959-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T16:47:39Z","timestamp":1698857259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-021-09959-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,4]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9959"],"URL":"https:\/\/doi.org\/10.1007\/s10555-021-09959-1","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,4]]},"assertion":[{"value":"5 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SKB is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. The other authors disclosed no potential conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest\/Competing interests"}}]}}